Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-074323
Filing Date
2025-05-19
Accepted
2025-05-19 16:05:22
Documents
1
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11261
  Complete submission text file 0000950170-25-074323.txt   12848
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SERES THERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Henn Matthew R (Reporting) CIK: 0001767321 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 25963873